[1] MBESE Z, KHWAZA V, ADERIBIGBE B A. Curcumin and its derivatives as potential therapeutic agents in prostate, colon and breast cancers[J]. Molecules,2019,24(23). doi:  10.3390/molecules24234386
[2] SALEHI M, MOVAHEDPOUR A, TAYARANI A, et al. Therapeutic potentials of curcumin in the treatment of non-small-cell lung carcinoma[J]. Phytother Res,2020,34(10):2557-2576. doi:  10.1002/ptr.6704
[3] 任金妹, 李曼, 谢宁, 等. 提高姜黄素口服生物利用度方法的研究进展[J]. 中国药房, 2018, 29(23):3303-3308. doi:  10.6039/j.issn.1001-0408.2018.23.29
[4]

KARTHIKEYAN A, SENTHIL N, MIN T. Nanocurcumin: a promising candidate for therapeutic applications[J]. Front Pharmacol,2020,11:487. doi:  10.3389/fphar.2020.00487
[5]

TANG J L, JI H Y, REN J M, et al. Solid lipid nanoparticles with TPGS and Brij 78: a co-delivery vehicle of curcumin and piperine for reversing P-glycoprotein-mediated multidrug resistance in vitro[J]. Oncol Lett,2017,13(1):389-395. doi:  10.3892/ol.2016.5421
[6]

PANDEY V, KOHLI S. Lipids and surfactants: the inside story of lipid-based drug delivery systems[J]. Crit Rev Ther Drug Carrier Syst,2018,35(2):99-155. doi:  10.1615/CritRevTherDrugCarrierSyst.2018016710
[7] 李秋萍, 戴俊东, 翟文文, 等. 单纯形网格法优化设计姜黄素-胡椒碱复方自微乳制剂处方[J]. 中国中药杂志, 2014, 39(20):3936-3944.
[8] 任金妹. 载姜黄素和胡椒碱固体脂质纳米粒给药系统的研究[D]. 哈尔滨: 哈尔滨医科大学, 2014.
[9]

KAZI M, SHAHBA A A, ALRASHOUD S, et al. Bioactive self-nanoemulsifying drug delivery systems (bio-SNEDDS) for combined oral delivery of curcumin and piperine[J]. Molecules,2020,25(7):1703. doi:  10.3390/molecules25071703
[10]

SLIKA L, MOUBARAK A, BORJAC J, et al. Preparation of curcumin-poly (allyl amine) hydrochloride based nanocapsules: piperine in nanocapsules accelerates encapsulation and release of curcumin and effectiveness against colon cancer cells[J]. Mater Sci Eng C Mater Biol Appl,2020,109:110550. doi:  10.1016/j.msec.2019.110550